Cardiac Function

Background Increases in cardiac biomarkers of myocardial injury and particularly cardiac troponin (cTn), in the absence of analytical confounders, define the presence of myocardial injury which in the proper clinical situation can lead to the diagnosis of acute myocardial infarction (AMI). Other biomarkers such as natriuretic peptides (NPs) facilitate the diagnosis and/or exclusion of heart failure (HF). These and other important biomarkers …